The enantiopurification of racemic
mixtures of chiral molecules
is important for a range of applications. Recent work has shown that
chiral group-directed photoisomerization is a promising approach to
enantioenrich racemic mixtures of BINOL, but increased control of
the diasteriomeric excess (de) is necessary for its
broad utility. Here we develop a cavity quantum electrodynamics (QED)
generalization of time-dependent density functional theory and demonstrate
computationally that strong light–matter coupling can alter
the de of the chiral group-directed photoisomerization
of BINOL. The relative orientation of the cavity mode polarization
and the molecules in the cavity dictates the nature of the cavity
interactions, which either enhance the de of the
(R)-BINOL diasteriomer (from 17% to ≈40%)
or invert the favorability to the (S)-BINOL derivative
(to ≈34% de). The latter outcome is particularly
remarkable because it indicates that the preference in diasteriomer
can be influenced via orientational control, without changing the
chirality of the directing group. We demonstrate that the observed
effect stems from cavity-induced changes to the Kohn–Sham orbitals
of the ground state.
Three
Ln2+ 18-crown-6 complexes of the formula Ln(18-crown-6)I2 (Ln = Sm, Eu, Yb) were isolated from the explicit synthesis
of the corresponding LnI2 salts with 18-crown-6 and tetrabutylammonium
tetraphenylborate in organic media under air-free conditions. Each
metal complex forms a distorted hexagonal bipyramidal geometry and
crystallizes in the monoclinic space group P21/n. Comparatively, crystallization of Ln(benzo-18-crown-6)I2 (Ln = Sm, Eu, Yb) from the reaction of LnI2 with
tetrabutylammonium tetraphenylborate and benzo-18-crown-6 in THF/ethanol
under similarly air-free conditions yields two polymorphs. The first
form, α, crystallizes in the monoclinic space group P21/c (or the nonstandard setting P21/n for α-Yb); whereas
the second polymorph, β, crystallizes in P
. While the geometries of the molecules only vary slightly,
the molecular packing and intramolecular contacts are quite different.
In the structure of β, π–π interactions between
the benzo- moieties of adjacent molecules are observed, whereas these
interactions are absent in α. Despite the similarities in these
classically 4f
n+1 lanthanide systems,
the complexes display distinct spectroscopic features in their respective
absorption and photoluminescence spectra. Broadband 5d → 4f photoluminescence was observed for
the Sm and Eu compounds in the NIR region and UV–visible region,
respectively. None of the three Yb compounds exhibit photoluminescence
UV–visible-NIR region; however, a unique photooxidation event
was observed resulting in characteristic Yb(III) 4f → 4f transitions in the NIR region of the
absorption spectra of these compounds. These findings are discussed
along with structural comparisons of the 18-crown-6 and benzo-18-crown-6
compounds as well as other reported Ln(II) crown complexes in the
literature.
Photoresponsive polymers, typically activated with direct excitation of an azobenzene moiety, are an intriguing class of materials for application as adaptive structures. Here, we introduce triplet excited state sensitization as a mechanism to harness light in a stilbene-based photopolymer (i.e., the carbon analogue of azobenzene). While the undoped film shows no response, the sensitized film exhibits polarization dependent bending under 445 nm irradiation via (1) sensitizer excitation, (2) triplet energy transfer, (3) stilbene isomerization, and (4) subunit reorientation. This work is the first to demonstrate stilbene-based photopolymers and triplet sensitization as a low energy light harvesting mechanism in photomechanics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.